$72.57
0.23% day before yesterday
Nasdaq, Nov 26, 10:01 pm CET
ISIN
US30214U1025
Symbol
EXPO

Exponent, Inc. Stock price

$72.57
+4.80 7.08% 1M
-3.63 4.76% 6M
-16.53 18.55% YTD
-26.42 26.69% 1Y
-28.31 28.06% 3Y
-10.75 12.90% 5Y
+46.73 180.84% 10Y
+69.09 1,986.06% 20Y
Nasdaq, Closing price Wed, Nov 26 2025
+0.17 0.23%

New AI Insights on Exponent, Inc. Insights AI Insights on Exponent, Inc.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$3.6b
Enterprise Value
$3.4b
Net debt
positive
Cash
$207.4m
Shares outstanding
50.0m
Valuation (TTM | estimate)
P/E
35.6 | 31.9
P/S
6.3 | 6.1
EV/Sales
6.0 | 5.8
EV/FCF
27.8
P/B
9.0
Dividends
DPS
$1.20
Yield 1Y | 5Y
1.7% | 1.1%
Growth 1Y | 5Y
7.1% | 9.6%
Payout 1Y | 3Y
53.1% | -
Increased
13 Years
Financials (TTM | estimate)
Revenue
$571.4m | $589.4m
EBITDA
$127.9m | $168.2m
EBIT
$117.9m | $147.5m
Net Income
$104.8m | $113.6m
Free Cash Flow
$122.9m
Growth (TTM | estimate)
Revenue
4.9% | 5.5%
EBITDA
6.4% | 30.1%
EBIT
6.5% | 23.4%
Net Income
-1.4% | 4.2%
Free Cash Flow
-20.0%
Margin (TTM | estimate)
Gross
93.0%
EBITDA
22.4% | 28.5%
EBIT
20.6%
Net
18.4% | 19.3%
Free Cash Flow
21.5%
Financial Health
Equity Ratio
54.2%
Return on Equity
25.9%
ROCE
19.4%
ROIC
16.6%
Debt/Equity
0.0
More
EPS
$2.0
FCF per Share
$2.5
Short interest
6.8%
Employees
1k
Rev per Employee
$480.0k
Show more

Is Exponent, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Exponent, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Exponent, Inc. forecast:

6x Buy
67%
3x Hold
33%

Analyst Opinions

9 Analysts have issued a Exponent, Inc. forecast:

Buy
67%
Hold
33%

Financial data from Exponent, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Oct '25
+/-
%
571 571
5% 5%
100%
- Direct Costs 40 40
12% 12%
7%
531 531
4% 4%
93%
- Selling and Administrative Expenses 373 373
3% 3%
65%
- Research and Development Expense - -
-
-
128 128
6% 6%
22%
- Depreciation and Amortization 10 10
5% 5%
2%
EBIT (Operating Income) EBIT 118 118
7% 7%
21%
Net Profit 105 105
1% 1%
18%

In millions USD.

Don't miss a Thing! We will send you all news about Exponent, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exponent, Inc. Stock News

Neutral
Seeking Alpha
28 days ago
Exponent, Inc. ( EXPO ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Catherine Corrigan - President, CEO & Director Richard Schlenker - Executive VP, CFO & Corporate Secretary Conference Call Participants Joni Konstantelos Andrew Nicholas - William Blair & Company L.L.C., Research Division Tyler Barishaw - Truist Securities, Inc., Research Division Karandeep Singhania...
Neutral
GlobeNewsWire
28 days ago
MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on December 19, 2025 to all common stockholders of record as of December 5, 2025.
Neutral
GlobeNewsWire
28 days ago
MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2025 ended October 3, 2025.
More Exponent, Inc. News

Company Profile

Exponent, Inc. is an engineering and scientific consulting company, which engages in the provision of engineering, scientific, environmental, and health consulting services. It operates through the following segments: Engineering and Other Scientific; and Environmental and Health. The Engineering and Other Scientific segment include technical consulting in different practices primarily in engineering. The Environmental and Health segment offers services in the area of environmental, epidemiology, and health risk analysis. The company was founded by Bernard Ross in 1989 and is headquartered in Menlo Park, CA.

Head office United States
CEO Catherine Corrigan
Employees 1,168
Founded 1967
Website www.exponent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today